Markets
Luke Kawa
5/7/25

US stocks scream higher near end of session on report Trump to ease chip export curbs

Stick save and a beauty.

US stocks had given up most of the gains inspired by confirmed trade talks with China after Apple tanked the market by saying that it was considering adding AI search in its browser, and then careened into negative territory once again after the Federal Reserve warned on heightened stagflationary risks for the US economy and President Trump said he wouldn’t unilaterally drop tariffs on China ahead of these discussions.

Then, near the end of the session, Bloomberg reported that the president is planning on easing export restrictions on semiconductors that were outlined by his predecessor, sending chip stocks sharply higher and pulling the market to session highs.

The S&P 500 and Nasdaq 100 ultimately closed up 0.4%, with the Russell 2000 gaining 0.3%.

Technology was the best-performing S&P 500 sector ETF, with Nvidia and Qualcomm pacing gains among chip stocks. Super Micro, which was deep in the red after issuing poor guidance just eight days after releasing ugly preliminary results, managed to pare most of its losses thanks to this report, as well.

Shares of Alphabet suffered a massive decline on testimony from Apple VP of Services Eddy Cue that underscored the challenge that AI poses to its dominance in search.

Disney surged double digits after crushing on earnings and boosting its full-year outlook, buoyed by strength in its parks business.

Novo Nordisk managed to gain even after cutting sales and profit guidance by indicating that it expects competition in the weight-loss drug space to subside in the second half of this year.

EV companies Rivian and Lucid tumbled after posting heavy losses.

Elsewhere in automakers in the red: Ford fell after saying it plans to raise the price of three vehicles built in Mexico by up to $2,000.

And in not-quite-car-company losers, Uber sank after missing on earnings and revenues.

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.